Publications found:
36,694
Sort by:
Fanconi Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Fanconi Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provid...
September 2021
93 pages
Gastritis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Gastritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides a...
September 2021
99 pages
Glycoprotein 41 (gp41) - Drugs in Development, 2021
US$ 3,500.00
Glycoprotein 41 (gp41) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitute...
September 2021
67 pages
Impetigo (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Impetigo (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides a...
September 2021
45 pages
Malaria (Infectious Disease) - Drugs in Development, 2021
US$ 2,500.00
Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an...
September 2021
450 pages
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...
September 2021
88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...
September 2021
53 pages
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021
US$ 2,000.00
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 202...
September 2021
113 pages
Tularaemia (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Tularaemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provid...
September 2021
44 pages
U.K. Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (Contract Outsourcing, In-house), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-use, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within Immediate U.K. Pharmacovigilance Market Growth & Trends The U.K. pharmacovigilance market size is expected to reach USD 510.37 million by 2028, acc...
September 2021
186 pages
Research Report on China's Alectinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 4.57 million new cancer cases were reported in China in 2020, including 820,000 lung cancer cases. 3 million cance...
September 2021
40 pages
Research Report on China's Anastrozole Market, 2021-2025
US$ 2,600.00
According to IARC’s 2020 World Cancer Report, the number of new cases of breast cancer reached 2.26 million in 2020, larger than that of lung cancer cases which was 2.2 million. Breast cancer has beco...
September 2021
40 pages
Research Report on China's Escitalopram Market, 2021-2025
US$ 2,600.00
Depression is the fourth leading disease in the world and is expected to become the first by 2030. However, the medical prevention and treatment of depression in China is still of low recognition rate...
September 2021
40 pages
Research Report on China's Exemestane Market, 2021-2025
US$ 2,600.00
Breast cancer is a common malignant tumor in menopausal women, and now ranks first among malignant tumors in women. Recently, the number of breast cancer patients in China has been increasing year by...
September 2021
40 pages
Research Report on China's Gefitinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 19.29 million new cancer cases were diagnosed worldwide in 2020, 4.57 million of which were in China, accounting f...
September 2021
40 pages
Research Report on China's Levetiracetam Market, 2021-2025
US$ 2,600.00
Epilepsy is second only to stroke as a common chronic neurological disorder characterized by excessive neuronal discharge in the brain resulting in recurrent, seizure and transient central nervous sys...
September 2021
40 pages
Research Report on China's Lobaplatin Market, 2021-2025
US$ 2,600.00
According to IARC of WHO, globally, there were 19.29 million new cases of cancer in 2020, among which 2.26 million were cases of breast cancer, surpassing the 2.2 million cases of lung cancer. Breast...
September 2021
40 pages
Research Report on China's Mesalazine Market, 2021-2025
US$ 2,600.00
Inflammatory bowel disease (IBD) is a chronic disease of the digestive system with unclear etiology, difficulty to cure, and recurrent attacks with multiple complications. The incidence of IBD in Chin...
September 2021
40 pages
Research Report on China's Roxatidine Market, 2021-2025
US$ 2,600.00
Peptic ulcers and gastrointestinal bleeding are common diseases in China with a large number of patients. Due to the fast pace of modern life, accelerated urbanization and great mental stress, the num...
September 2021
40 pages
Research Report on China's Sorafenib Market, 2021-2025
US$ 2,600.00
Hepatocellular carcinoma (HCC) is the most common type of chronic liver cancer in adults and the most common cause of death in patients with cirrhosis. Hepatocellular carcinoma (HCC) is the third most...
September 2021
40 pages
Research Report on China's Venlafaxine Market, 2021-2025
US$ 2,600.00
Depression is the result of a complex interplay of social, psychological and physical factors. People who experience adverse events in their lives are more likely to develop depression. Depression can...
September 2021
40 pages
Research Report on China's Zoledronic Acid Market, 2021-2025
US$ 2,600.00
Osteoporosis is a metabolic disease caused by a combination of endocrine, nutritional, immune, and genetic factors, and is characterized by increasing bone fragility and fracture due to a gradual decr...
September 2021
40 pages
Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) - Global Forecast to 2026
US$ 2,970.00
... the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally ... report will help the market leaders/new entrants in this market in the following ways: 1. This report segments the market into application types ...
September 2021
334 pages
